Truist Financial maintained a Buy rating on LendingTree, noting the online loan marketplace could benefit from Trump-era tariffs.
1 report, 0 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial maintained a Buy rating on LendingTree, noting the online loan marketplace could benefit from Trump-era tariffs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
LendingTree
American fintech company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- LendingTree operates an online consumer platform in the United States.
- MarketBeat provides analyst ratings for LendingTree, an online consumer platform that helps users connect with Medicare insurance.
- Bankrate, LendingTree, and the Federal Reserve Bank are providing data on consumer financial services, noting that high market rates are disappointing consumer hopes.
- Truist Financial raised price targets and issued buy ratings, while filings were required under SEC oversight involving Fifth Third Bancorp and JPEG.
- LendingTree's Matt Schulz is chief consumer finance analyst as the Fed communicates policy decisions to Congress.
Coverage
Newest first; wire copies grouped- Unknown outlet